Monthly Prescribing Reference

Dotarem Approved for Use in Children Under Two Years Old

Dotarem is a macrocyclic and ionic gadolinium-based contrast medium The Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine; Guerbet) for intravenous use with magnetic ...
Monthly Prescribing Reference

Dotarem Approved; Contrast Agent for MRIs in Brain, Spine

Guerbet announced that the FDA has approved Dotarem (gadoterate meglumine) injection, a gadolinium-based contrast agent (GBCA), for intravenous use with magnetic resonance imaging in the brain, spine, ...
Medical Xpress

Dotarem approved for nervous system MRIs

(HealthDay)—Dotarem (gadoterate meglumine) has been approved by the U.S. Food and Drug Administration as a contrast agent for use in MRIs of the brain, spine and other parts of the central nervous ...
Pharmabiz

US FDA committee recommends approval of Guerbet's Dotarem

Guerbet, the contrast agent specialist for medical imaging, announced that the Medical Imaging Drugs Advisory Committee to US Food and Drug Administration (FDA) has voted unanimously by votes of 17 to ...